About Index Trending news
Analyze
Top 50 Pricing
Syros Pharmaceuticals

Syros Pharmaceuticals

Work at Syros Pharmaceuticals? Add yourself to this profile

Syros Pharmaceuticals

Syros Pharmaceuticals is a life sciences company that is focused on treating diseases by mapping gene regulatory circuits.

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding Show all
Venture capital (Series C)
$40,000,000
Redmile Group, Polaris Partners, Aisling Capital, +5
Venture capital (Series B)
$53,000,000
Alexandria Venture, ARCH Venture Partners, Aisling Capital
Employees

Team size

10+
Locations
HQ
Headquarters
Xconomy

Syros Cuts Price But Bags $50M in IPO to Fuel Cancer Drug Trials

Stock markets Health Science
Xconomy

Syros Files For IPO to Push “Gene Control” Drugs Through First Trials

Science Health Funding
$40,000,000 Venture capital (Series C)
PE HUB , FinSMEs

Syros Pharma raises $40 mln